Cancer Treatment Reviews
Volume 30, Issue 6 , Pages 577-582, October 2004

Initial high dose chemotherapy plus autologous stem cell support improves survival outcomes compared with a standard CHOP regimen in people with higher intermediate risk aggressive lymphoma:☆☆☆☆☆☆

Abstracted from: Milpied N, Deconinck E, Gaillard F, et al. Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. N Engl J Med 2004;350:1287–95.

Department of Internal Medicine, University of Bonn, Germany

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Sources of funding: Supported in part by grants from Schering Laboratories of France.

☆☆ For Correspondence: Noel Milpie, University Hospital of Nantes, Nantes, France. noel.milpied@chu-nantes.fr.

☆☆☆ Abstract provided by Bazian Ltd., London.

PII: S0305-7372(04)00120-3

doi:10.1016/j.ctrv.2004.06.004

Cancer Treatment Reviews
Volume 30, Issue 6 , Pages 577-582, October 2004

Article Tools